While injectable BPC-157 has been widely studied for tissue repair, the oral formulation offers unique advantages by delivering the peptide directly to the gastrointestinal tract, where it can exert both local and systemic healing effects
No membership
A 43-amino acid synthetic peptide modeled after thymosin beta-4.- Reported to regulate actin dynamics via its LKKTETQ sequence, thereby influencing cellular migration and motility.- May also elevate microRNA-146a, which suppresses inflammatory pathways involving IRAK1 and TRAF6.- Preclinical studies point toward roles in wound contraction, tissue vascularization, and cardiac resilience under stress
Hsieh MJ, Liu HT, Wang CN, Huang HY, Lin Y, Ko YS, Wang JS, Chang VH, Pang JS
Vital Flow uses screening, nurse-administered care, and physician-led protocols to help guide safe use